PG201 protects mice from experimental autoimmune encephalomyelitis via suppression of effector T cell activation

Conclusion These findings indicate that PG201 may exert strong immunomodulatory effects in the EAE model via suppression of T cell activation, and that PG201 is a therapeutic reagent for the treatment of multiple sclerosis. Graphical abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research